The economic impact of diabetes through lost labour force participation on individuals and government: evidence from a microsimulation model by Schofield, Deborah et al.
Schofield et al. BMC Public Health 2014, 14:220
http://www.biomedcentral.com/1471-2458/14/220RESEARCH ARTICLE Open AccessThe economic impact of diabetes through lost
labour force participation on individuals and
government: evidence from a microsimulation
model
Deborah Schofield1, Michelle M Cunich2*, Rupendra N Shrestha2, Megan E Passey3, Lennert Veerman4,
Emily J Callander2, Simon J Kelly5 and Robert Tanton5Abstract
Background: Diabetes is a costly and debilitating disease. The aim of the study is to quantify the individual and
national costs of diabetes resulting from people retiring early because of this disease, including lost income; lost
income taxation, increased government welfare payments; and reductions in GDP.
Methods: A purpose-built microsimulation model, Health&WealthMOD2030, was used to estimate the economic
costs of early retirement due to diabetes. The study included all Australians aged 45–64 years in 2010 based on
Australian Bureau of Statistics’ Surveys of Disability, Ageing and Carers. A multiple regression model was used to identify
significant differences in income, government welfare payments and taxation liabilities between people out of the
labour force because of their diabetes and those employed full time with no chronic health condition.
Results: The median annual income of people who retired early because of their diabetes was significantly lower
(AU$11 784) compared to those employed full time without a chronic health condition who received almost five times
more income. At the national level, there was a loss of AU$384 million in individual earnings by those with diabetes, an
extra AU$4 million spent in government welfare payments, a loss of AU$56 million in taxation revenue, and a loss of
AU$1 324 million in GDP in 2010: all attributable to diabetes through its impact on labour force participation. Sensitivity
analysis was used to assess the impact of different diabetes prevalence rates on estimates of lost income, lost income
taxation, increased government welfare payments, and reduced GDP.
Conclusions: Individuals bear the cost of lost income in addition to the burden of the disease. The Government
endures the impacts of lost productivity and income taxation revenue, as well as spending more in welfare payments.
These national costs are in addition to the Government’s direct healthcare costs.
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Diabetes affects millions of individuals worldwide, and the
number of sufferers is expected to increase [1]. Indeed, the
global burden of diabetes (measured in Disability Adjusted
Life Years or DALYs) has already increased by 43.1% over
the last 20 years [2]. Globally, there has been a significant
increase in the number of deaths due to diabetes. The Glo-
bal Burden of Disease Study 2010 reports 1.3 million deaths
due to diabetes worldwide in 2010 which is twice as many
as in 1990 [3]. For these reasons, diabetes has been labelled
“one of the most common, severe, and costly diseases” [4].
In Australia diabetes is a ‘national health priority area’
in recognition of the substantial individual and govern-
ment costs of the disease [5]. In 2007 about 4% of the
Australian population has been diagnosed with diabetes
[6]. In 2004 it was estimated that almost AU$1 billion
had been spent on direct health system costs for diabetes
in Australia, and that the cost of treating diabetes is ex-
pected to rise by over 400% from 2003 to 2033 [7,8].
While these direct costs are large, there is evidence inter-
nationally that the indirect costs of diabetes are greater than
the direct costs [4]. These indirect costs are mostly attrib-
uted to lost productivity, with diabetes affecting an individ-
ual’s ability to engage in employment and hence reducing
their income [9]. Indeed, a recent study of older working-
age Australians found that diabetes was the eighth most
common reason for not being in the labour force [10].
With the health burden of the condition being so
large, the cost of diabetes on economies worldwide is
correspondingly significant. In Europe, the extra health-
care and labour productivity costs associated with dia-
betes have become pressing challenges for governments.
Consequently, several European stakeholders (such as
The Fit for Work Europe Coalition) have put forward
the case for counting work as a relevant outcome meas-
ure in health investment decisions, especially decisions
involving patients with long-term chronic illnesses [11].
With the ageing of the global population, there is in-
creasing focus on the need to retain older workers [12]. In
Australia, 38% of workers aged 45–64 years who have dia-
betes are not in the labour force, representing a pool of
people who may have participated if they did not have this
disease [10]. Australia, like other developed countries, will
need to maximise the labour force participation of its
older workers to maintain adequate government revenue
to fund health carefor an ageing population [13]. This
makes the impact of diabetes on the labour force partici-
pation of older workers a vital issue.
This study examines the costs of early retirement due to
diabetes. It estimates, for Australians aged 45–64 years,
the amount of lost income to individuals, lost income tax-
ation revenue to government, increased government wel-
fare payments and lost Gross Domestic Product (GDP) due
to these individuals leaving the labour force prematurelybecause of their diabetes. It also estimates the difference in
these values between people who have retired early due to
diabetes and those in full and part time employment with
no chronic health condition. Most of this burden is, in
principle, preventable. Diabetes Australia (2013) estimates
that 89% of people aged 40–59 years with diabetes in
Australia have Type 2 diabetes [14], which is associated
with unhealthy lifestyles (unmanaged cholesterol, blood
pressure; smoking; unhealthy food choices; sedentary life-
style) and obesity [15]. We undertook sensitivity analysis
where our estimates of lost income, lost income taxation,
extra government welfare payments and lost GDP were re-
duced in line with this prevalence rate to estimate the po-
tentially preventable component of these losses.Methods
Data
We used Health&WealthMOD2030, a microsimulation
model of health, disability and labour force participation,
to analyse the impact of diabetes on labour force participa-
tion, individual income, and government income (revenue)
and spending. Health & WealthMOD2030 was purposely
designed to evaluate the economic consequences of ill
health on the labour force participation of Australians
aged 45–64 years.
The base population of Health & WealthMOD2030 was
unit record data for individuals aged 45–64 years drawn
from the pooled data from the 2003 and 2009 Surveys of
Disability, Ageing and Carers (SDACs) conducted by the
Australian Bureau of Statistics (ABS) [16,17]. These na-
tionally representative (Australian) household survey data
provide information on individual characteristics (such as
age, sex, family type, and state of residence), socioeco-
nomic characteristics (such as highest level of education,
income, type of home ownership, and government welfare
payments), labour market characteristics (such as labour
force participation, employment restrictions, and retire-
ment), and health and disability characteristics (such as
chronic conditions, health status, type and degree of dis-
ability, support and care requirements) for each person in
the household. Australian Universities are provided with
free access to the ABS unit record data that underpins this
study under the Vice Chancellor’s Agreement.
Respondents in the SDACs reported what their main
and other chronic health conditions were, and their re-
sponses were classified by the ABS [16,17]. In this study,
respondents were considered to be out of the labour force
due to diabetes if they stated they were out of the labour
force due to illness and listed diabetes as their main
chronic health condition. Like we did here, previous stud-
ies [10,18,19] have extracted data from national household
survey data on people who have left the labour force be-
cause of their ill health or disability and used “main
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largest (disabling) impact on individuals.
Whilst we cannot identify the type of diabetes people
have from the SDAC data (as it is a single option in the
survey), we note that the type of diabetes these people
have is likely to be Type 2 diabetes based on the age group
of study participants (Diabetes Australia reports that 89%
of the diabetes prevalence of people aged 40–59 years in
Australia is Type 2 diabetes) [14]. The 2003 and 2009
SDACs data were reweighted to reflect the profile of the
2010 Australian population aged 45–64 years using a
reweighting algorithm GREGWT. The mathematical tech-
nique is described in Singh and Mohl (1996) [20] and an
implementation of the same algorithm for small area esti-
mation is described in Tanton et al. (2011) [21]. The ABS
developed this algorithm, and related software, and com-
monly uses it to reweight their survey data. This reweight-
ing procedure was used to account for the expected
changes in disability and illness, demographics, labour
force participation and other features of the population
that occurred between the years for which we have data
(2003 and 2009) and 2010.
The SDACs included only limited economic data,
which were presented in ranges. Thus more detailed in-
formation on income, welfare payments and individual
income taxes (and wealth) were derived from a separate
microsimulation model called the Australian Population
and Policy Simulation Model (APPSIM). APPSIM is a
dynamic population microsimulation model that was
developed to provide a snapshot output of demographic
and economic characteristics (such as income and gov-
ernment welfare payments) of the Australian population
in each year. It is developed and maintained by the
National Centre for Social and Economic Modelling
(NATSEM; http://www.natsem.canberra.edu.au). De-
tailed economic information from the APPSIM snap-
shot output for the year 2010 were imputed onto the
base population of Health & WealthMOD2030 by
identifying persons with similar characteristics on the
concatenated SDACs and APPSIM. We imputed this
more detailed income and wealth information onto
Health&WealthMOD2030 using a process commonly
used in microsimulation modelling called synthetic
matching [22]. Ten variables that were common to both
datasets and strongly related to income were chosen as
matching variables for synthetic matching: labour force
status (4 groups: employed full time, employed part
time, unemployed, not in the labour force), income
unit type (4 groups: married couple with dependents,
married couple only, one parent with dependents,
one person), income quintile (5 groups: income quin-
tiles 1st-5th), receiving age pension (2 groups: yes or no),
receiving disability support pension (2 groups: yes or
no), sex (2 groups: male or female), age group (4 groups:45–49 years, 50–54 years, 55–59 years, 60–64 years),
hours worked per week (5 groups: 1–15 hours, 26–
24 hours, 25–34 hours, 35–40 hours, 41-plus hours),
highest educational qualification (2 groups: university
or non-university) and home ownership (2 groups: yes
or no).
Statistical analysis
Descriptive analysis was undertaken to establish the mean
and median annual income, income taxation payments,
and government welfare payments received by individuals
employed full time, part time, and not in the labour force
because of diabetes, expressed in 2010 Australian dollars.
A multiple regression model of the log of annual in-
come was used to assess the differences between annual
incomes of people in employment (full time) who re-
ported they did not have a chronic health condition and
people not in the labour force who reported they had
left because of their illness and nominated diabetes as
their main chronic condition. Similar models were esti-
mated for the logs of annual welfare payments and tax
liability. Each regression model was adjusted for the (in-
dividual) effects of age, sex and education. Modelling
was undertaken on log-transformed data to satisfy the
assumptions of the linear regression model. Diagnostic
tests confirmed that these assumptions were satisfied.
The impact of diabetes on national GDP was estimated
using the Commonwealth Treasury’s GDP formula:
GDP ¼ GDP=Hð Þ H=EMPð Þ EMP=LFð Þ LF=Pop15þð ÞPop15þ
where GDP =Gross Domestic Product; H = total hours
worked; EMP = total number of persons employed; LF =
size of the labour force; and Pop15+ = population aged
15 years and over [13].
All analyses were conducted in SAS V9.3 (SAS Insti-
tute Inc., Cary, NC, USA). All statistical tests were two
sided with the significance level set at 5%.
Sensitivity analysis
Initial data extraction from the 2003 and 2009 SDACs
was of people aged 45–64 years who reported they had
left the labour force because of ill health and that their
main chronic condition was diabetes.
Diabetes Australia reports that 89% of people aged
40–59 years with diabetes have Type 2 diabetes in
Australia [14]. We conducted sensitivity analysis using
this proportion of people with Type 2 diabetes to repre-
sent the proportion of people with the disease who could
be expected to remain in the labour force if the disease
were prevented. These estimates of the economic costs
of diabetes represent the potentially preventable compo-
nent of the overall losses.
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Amongst people surveyed in the SDACs aged 45–64 years,
345 were employed full time with diabetes; 105 were
employed part time with diabetes; 46 people were out of
the labour force because of diabetes; 6 606 were employed
full time with no chronic health condition, and 2 373 were
employed part time with no chronic health condition.
After weighting these data to 2010, these survey records
corresponded to 88 900 employed full time with diabetes,
25 330 employed part time with diabetes, 11 300 individ-
uals out of the labour force because of diabetes, 1 413 500
employed full time with no chronic health condition, and
467 800 employed part time with no chronic health condi-
tion, in the age group 45–64 years within the Australian
population.
Of the people who reported they left the labour force due
to diabetes, 13% reported having diabetes only (i.e. 1
chronic condition), 11% reported 2 chronic conditions, 26%
reported 3 chronic conditions, and 50% reported 4 or more
chronic conditions. Common chronic conditions for people
out of the labour force due to diabetes were hypertension,
heart disease, stroke and high cholesterol, which are associ-
ated with Type 2 diabetes (http://www.diabetesaustralia.
com.au/Understanding-Diabetes/What-is-Diabetes/Type-2-
Diabetes/).
While those who worked full time and reported dia-
betes as their main condition had lower incomes than
those who worked full time and had no chronic health
condition, there was no significant difference between
the two groups.
Those who were out of the labour force as a result of
their diabetes had a median annual income (income de-
rived from all sources including welfare payments) of $11
784. This is approximately half of the median annual in-
come of workers employed part time with no chronic con-
dition ($21 257 per year) and approximately one fifth of
the annual income of those employed full time with no
chronic condition, $54 795 (Table 1). People out of the
labour force because of their diabetes also had a lower me-
dian income compared to those with diabetes who were
working either part time ($26 032) or full time ($52 655).
Of their entire annual income, those people out of the
labour force because of their diabetes received a median of
$986 per year in government welfare payments, whereas
those in the labour force received none as a median value.
Those out of the labour force because of their diabetes
paid effectively no (median) tax per year whereas those
employed in full time work without a chronic health con-
dition paid a median amount of $9 814 per year in tax.
Compared to those in full time work and without a
chronic health condition (and adjusted for age, sex and
education), people out of the labour force due to dia-
betes received approximately 88% less in total income
per year, on average (Table 2). This group also paid asignificantly smaller amount in taxes per year, and re-
ceived a significantly larger amount in government wel-
fare payments per year than those employed without a
chronic condition or employed with diabetes.
The national impact of diabetes when it causes early re-
tirement is $383.9 million in lost income earnings by those
with diabetes, $56.4 million in lost income taxation rev-
enue, and an extra $3.5 million in government welfare
payments per year (Table 3) assuming that otherwise those
with diabetes would have the same labour force participa-
tion rate and full time and part time employment rates as
people without a chronic health condition. As a result of
the (national) labour force losing 11 310 workers early be-
cause of diabetes, there was a loss of $1 324 million in
GDP in 2010.
After taking into account the Type 2 diabetes prevalence
rate for people aged 40–59 years in Australia [14], the num-
ber of people out of the labour force with this potentially
preventable form of the disease was 10 066. The national
impacts were $341.7 million in lost income earnings by
those with diabetes, $50.2 million in lost income taxation
revenue, and an additional $3.1 million in government wel-
fare payments in 2010 (Table 3). As a consequence of losing
these workers prematurely because of their (Type 2) dia-
betes, there was a loss of $1 179 million in GDP in 2010.
Discussion
It is evident that diabetes is a costly disease. Diabetes com-
prises a substantial amount of government health funding,
at AU$812 million in 2004-05 [8]. The majority of this
funding is spent on hospital stays and prescription pharma-
ceuticals, followed closely by non-hospital medical services.
In addition, the indirect costs of diabetes are considerable
at the individual and national levels. People aged 45–
64 years who left the labour force early because of diabetes
had a median total annual income of only $11 784 whereas
those working full time without a chronic health condition
earned approximately five times this amount. These early
retirees with diabetes also received a lower median income
compared to those in the labour force with diabetes. The
national impact of diabetes through losing 11 300 people
aged 45–64 years from the labour force because of their
diabetes was estimated to be $384 million in lost income
earnings by those with diabetes, $56 million in lost income
taxation revenue, $4 million in additional government wel-
fare payments, and overall $1 324 million in lost GDP in
2010. After taking into account the type of diabetes that is
potentially preventable for these workers [14], the national
impacts were $341.7 million in lost income earnings by
those with diabetes, $50.2 million in lost income taxation
revenue, and an extra $3.1 million in government welfare
payments in 2010. As a consequence of losing 10 066
workers prematurely because of Type 2 diabetes, there was
a loss of $1 179 million in GDP in 2010.
Table 1 Average and median* annual income, government welfare payments# and tax liability by labour force status
for the Australian population aged 45–64 years, 2010
Labour force status N Annual income
(AU$) received
by individuals
Annual welfare income
(AU$) received
by individuals
Annual tax (includes
Medicare levy) (AU$)
paid by individuals
Surveyed weighted
records population
Mean SD Median Mean SD Median Mean SD Median
Employed full time, no chronic
health condition
6 606 1 413 511 63 190 35 182 54 795 593 2 462 0 12 894 11 314 9 814
Employed part time, no chronic
health condition
2 373 467 796 29 068 30 037 21 257 1 960 4 351 0 3 895 8 391 865
Employed full time, with diabetes 345 88 889 60 389 30 117 52 655 305 1 728 0 11 874 10 054 8 937
Employed part time, with diabetes 105 25 329 30 857 25 743 26 032 2 377 5 048 0 3 966 7 691 1 366
Not in labour force due to diabetes 46 11 310 13 900 16 727 11 784 6 048 7 296 986 1 040 4 068 0
*All results given in 2010 Australian dollars (AU).
#Government welfare payment in APPSIM (our data source for financial measures) includes:
•Aged pension – this payment provides income support and access to a range of concessions for eligible older Australians (aged 64–65 years and older).
•Disability support pension – financial support for people who have a physical, intellectual or psychiatric condition that prevents them from working or who are
permanently blind.
•Newstart allowance – financial assistance for people who are looking for work.
•Youth allowance – financial assistance for people aged 16–24 years who are studying full time, undertaking a full time Australian apprenticeship, training or
looking for work.
•Carer payment – an income support payment for people who personally provide constant care in the home of someone with a severe disability, illness or who is
frail aged.
•Family tax benefits – a two part payment that assists with the cost of raising children (A and B).
Information on these payments can be found at: http://www.humanservices.gov.au/customer/services.
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has a significant impact on the ability of individuals to
participate in the labour force. In Canada, for example,
diabetics with complications were twice as likely to be
out of the labour force compared to non-diabetics in the
working-age population [9]. Similar findings have been
presented in studies based on the United States and
Australian working-age populations [5,23,24]. Comple-
menting these studies on the direct impact of diabetes
on labour force participation, others have focused on the
indirect costs of diabetes through lost labour productiv-
ity and work absences of sufferers [4,24]. These studies
support the findings reported in this paper, concluding
that diabetes affects individual income through prevent-
ing labour force participation.
There are several limitations of the analysis. Firstly, the
analysis is limited to people aged 45–64 years who re-
ported that they are no longer in work as a result of hav-
ing diabetes. It does not include other forms of limited
labour force participation such as absenteeism (taking
time off work while sick) and presenteeism (attending
work while sick resulting in reduced productivity at work),
nor does it estimate the value of lost GDP through early
mortality, or the economic impact of carers having to give
up work. Although the study did not set out to cover these
areas, an estimate of the wider economic impact of dia-
betes through lost labour force participation would most
likely result in even higher indirect economic impacts.
Secondly, the age range of study participants is limited
to 45–64 years, as this is the age range which experiencesthe largest economic impact because of Type 2 diabetes
prevalence and plans for retirement. Latest data shows
that Type 2 diabetes affects 7% of people with diabetes
aged 0–20 years, 54% of people with diabetes aged 21–
39 years, 89% of people with diabetes aged 40–59 years,
and 94% of people with diabetes aged 60 years or older
[14]. Data for people under 45 years was not analysed be-
cause the paper sought to evaluate the costs associated
with the age group with the highest proportion of the pre-
ventable form of diabetes who, in turn, would incur the
largest costs of the disease through premature exit from
the labour force.
Lastly, this study takes the human capital approach to
valuing productivity costs (i.e. the patient’s perspective) and
thus counts any hour not worked as an hour lost and
values these hours. It does not consider potential ‘friction
periods’ – the time in which a replacement employee may
be found. The friction method takes an employer’s per-
spective and only measures as lost those hours not worked
until another employee takes over the work of the person
who is ill [25-27]. The main difference in outcomes of the
two approaches stems from the different time horizon
used to measure and value productivity costs. The human
capital approach, by considering every hour not worked as
an hour lost perhaps until the individual reaches the age
of retirement, tends to lead to higher costs. Thus the hu-
man capital approach may overestimate productivity
losses. But the friction cost approach has also been criti-
cised as is values lost labour during a short time period –
the friction period – which is a time assumed until the
Table 2 Differences in average weekly income, welfare payments and tax liability between labour force status,
adjusted for age group, sex and education, for the Australian population aged 45–64 years, 2010
Labour force
status
Income Welfare income Tax liability
(includes Medicare levy)
% difference 95% CI p-value % difference 95% CI p-value % difference 95% CI p-value
Employed full time,
no chronic
health condition
Reference Reference Reference
Employed part time,
no chronic
health condition
−56.3 (−58.7, −53.7) <.0001 71.9 (42.5,107.2) <0.0001 −96.1 (−97.0,-95.0) <.0001
Employed full time,
with diabetes
−6.5 (−13.2,0.7) 0.0746 24.9 (3.4,50.8) 0.0208 −24.6 (−42.0,-1.9) 0.0352
Employed part time,
with diabetes
−52.4 (−60.2,-43.1) <.0001 112.3 (0.4,348.7) 0.0488 −92.6 (−96.8,-83.0) <.0001
Not in labour force
due to diabetes
−88.3 (−95.6, −69.3) <.0001 3 819.8 (793.5, 17 095) <0.0001 −99.8 (−100.0, −99.2) <.0001
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quently, the friction cost approach may underestimate
productivity losses. Limited empirical evidence is available
on the differences in outcomes derived from these ap-
proaches; but see van den Hout (2010) [26] for a compari-
son of outcomes in relation to rheumatoid arthritis.
In our study, we use the human capital approach
which represents the perspective of the person who has
become too ill to work, but to be conservative only re-
port costs over a 12 month period. We also reported on
government impacts in terms of welfare payments and
lost taxation revenue as well as national GDP impacts.
This choice was made because it seemed to best reflect
the economic environment in Australia. In Australia,
many vacant positions are not filled by people who are
unemployed, but are more likely to be filled by someone
moving from another position, thus creating another job
vacancy. This is partly due to the need to find an appro-
priate skills match between the position and the appli-
cant and barriers to labour mobility partly caused by
Australia being a large country [28]. For example, there
have been labour shortages in mining, however these po-
sitions are usually in remote areas and families with
young children or whose partner is in employment may
not be able to move. This results in a relatively long dur-
ation between unemployment and finding another job.
In Australia, someone who is unemployed and on a gov-
ernment unemployment benefit (called Newstart inTable 3 National impact of diabetes (adjusted for age, sex an
45–64 years, 2010
Income (million AU$)
Not in labour force due to diabetes (n = 11 310) 383.9
Not in labour force due to preventable form
of diabetes (type 2 diabetes; n = 10 066)
341.7
Note: Based on the differences between persons not in the labour force due to diab
with no chronic health condition.Australia), on average, has a little over three years before
they find a new position and are no longer eligible for
an unemployment benefit [29]. Further, when someone
leaves the labour force too ill to work, they may become
eligible for a Disability Support Pension, which is about
50% higher than the unemployment benefit, thus the wel-
fare costs to government of a person too ill to work are
higher than someone who is simply unemployed. (http://
www.humanservices.gov.au/customer/enablers/centrelink/
disability-support-pension/payment-rates) [30]. In terms of
GDP, if someone unemployed were to fill a newly created
position this would contribute to GDP growth, whereas fill-
ing a vacancy created by someone leaving the workforce
permanently when they become chronically ill generates no
growth.
For these reasons we felt that for this study, the friction
cost method, which assumes that 3–6 months after some-
one leaves the labour force someone else will have filled
the position, and thus the aggregate impact after 3–
6 months is zero [26] would underestimate the effects of
leaving the workforce due to ill health not only for the per-
son themselves, who are faced with an ongoing loss of in-
come, but also the impacts on unemployment benefits
and GDP which are longer in duration in Australia than
the 3–6 month provision in the friction cost method.
Interventions that increase the labour force participa-
tion rate of people with chronic conditions (such as dia-
betes) are likely to yield benefits to both individualsd education) for the Australian population aged
Transfer payments (million AU$) Taxation revenue (million AU$)
3.5 56.4
3.1 50.2
etes and the weighted average of persons employed full time and part time
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pharmacological (such as metformin) and lifestyle interven-
tions to prevent or delay the development of Type 2 dia-
betes in high risk individuals are effective and cost-effective
[31-33], and have the potential to increase the labour force
participation rate of older workers with this form of dia-
betes which, in turn, may reduce income losses [34].
Reduced income amongst those who retire early due to
diabetes may also lead to inadequate (personal) finance for
future health care needs [35]. One study in the United
States found a high correlation between chronic illness
and financial stress, with one quarter of bankruptcies at-
tributable to chronic illness [35]. This may reflect families
being ill-prepared to deal with the financial implications of
caring for a family member with a long-term health condi-
tion. In Australia, older workers who retire early due to
diabetes have a value of total wealth that is 89.6% lower
(includes savings, superannuation, and property) than that
of older full time workers with no health condition [18],
leaving them with minimal savings to cover their health
care costs. However, universal health coverage in Australia
implies reduced ability to pay from reduced savings is
somewhat moderated (although 30% of health care costs
in Australia are private coming from individuals, private
health insurance and other non-government sources [36]).
Nonetheless, patients without savings for private care
often face long waiting times for appropriate care in the
public system. Type 2 diabetes is increasing in prevalence
worldwide. It is also becoming more common amongst
the working-age population, particularly those aged 45–
64 years [23]. Consequently, the impact of this form of
diabetes on labour force participation and the flow-on na-
tional impacts are likely to become greater over time. To
help reduce the costly outcomes of premature retirement
because of diabetes, investment in prevention (Type 2 dia-
betes) seems desirable. This aligns with the health platform
of the current Australian Government which recognises
that prevention of chronic diseases can help increase labour
force participation. It has been acknowledged that preven-
tion will not only improve the health of the general popula-
tion but help to maintain economic growth by sustaining
human resources in production [13,37], with the added ad-
vantage of helping Government to ensure that future reve-
nues will be sufficient to fund the health care of its ageing
population [13].
Conclusions
Individuals incur significant costs from lost income due to
diabetes as well as the burden of the disease itself. The
Government incurs the impacts of lost labour productivity
and income taxation revenue, and increased expenditure
on welfare payments in addition to direct healthcare costs.
These financial costs provide further support for the im-
portance of preventing this disabling condition.Competing interests
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